Gary Lyons
Chairman chez TRAVERE THERAPEUTICS, INC.
Fortune : 27 M $ au 31/03/2024
Profil
Gary A. Lyons est un homme d'affaires qui a fondé GL Biomed et qui a été à la tête de 5 entreprises différentes. M. Lyons est président de Rigel Pharmaceuticals, Inc. et de Travere Therapeutics, Inc. et président de GL Biomed. M. Lyons est également membre du conseil d'administration de Neurocrine Biosciences, Inc. (ancien président, directeur général et directeur), d'Eledon Pharmaceuticals, Inc. et de Brickell Biotech, Inc. Il a précédemment occupé le poste de président exécutif de NeurogesX, Inc, de vice-président chargé du développement commercial et des ventes chez Genentech, Inc. et de directeur des ventes - American Critical Care chez American Hospital Supply Corp. M. Lyons a obtenu un diplôme de premier cycle à l'université du New Hampshire et un MBA à la Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/12/2023 | 193 697 ( 0,19% ) | 27 M $ | 31/03/2024 | |
| 17/05/2023 | 44 500 ( 0,06% ) | 343 095 $ | 31/03/2024 | |
| 26/05/2023 | 75 000 ( 0,04% ) | 111 000 $ | 31/03/2024 | |
| 01/05/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Gary Lyons
| Sociétés | Poste | Début |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Director/Board Member | 01/02/1993 |
| RIGEL PHARMACEUTICALS, INC. | Director/Board Member | 01/10/2005 |
| TRAVERE THERAPEUTICS, INC. | Chairman | 18/05/2016 |
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Director/Board Member | 01/01/2018 |
| GL Biomed | Founder | 01/03/2008 |
Anciens postes connus de Gary Lyons
| Sociétés | Poste | Fin |
|---|---|---|
| FRESH TRACKS THERAPEUTICS, INC. | Director/Board Member | 02/10/2023 |
| ELEDON PHARMACEUTICALS, INC. | Director/Board Member | 21/06/2023 |
Vical, Inc.
 Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Director/Board Member | 01/08/2019 |
| PLUS THERAPEUTICS, INC. | Director/Board Member | 30/01/2019 |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Gary Lyons
| University of New Hampshire | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 8 |
|---|---|
| PONIARD PHARMACEUTICALS, INC. | Health Technology |
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| HUMANIGEN, INC. | Health Technology |
| PLUS THERAPEUTICS, INC. | Health Technology |
| TRAVERE THERAPEUTICS, INC. | Health Technology |
| ELEDON PHARMACEUTICALS, INC. | Health Technology |
| FRESH TRACKS THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 10 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | Health Technology |
Abbott Biotherapeutics Corp.
 Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Abbott Biotherapeutics Corp. engages in the identification and development of oncology therapeutics. The firm's products in development include Daclizumab, a monoclonal antibody in Phase IIb clinical studies that binds to the alpha chain of the interleukin-2 receptor on activated T cells; and Volociximab, a chimeric monoclonal antibody in Phase I clinical studies that inhibits the functional activity of a protein in activated endothelial cells. The company was founded in 2008 and is headquartered in Redwood City, CA. | Health Technology |
| American Hospital Supply Corp. | Health Technology |
NeurogesX, Inc.
 NeurogesX, Inc. Pharmaceuticals: MajorHealth Technology NeurogesX, Inc. developed and commercialized novel pain management therapies. The company was founded by Wendye R. Robbins on May 28, 1998 and was headquartered in San Mateo, CA. | Health Technology |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty Management LLC (Healthcare Royalty) is a private equity subsidiary of Cowen, Inc. founded in 2007 by Gregory Brown. The firm is headquartered in Stamford, Connecticut. | Finance |
| GL Biomed | |
| Kalobios Pharmaceuticals, Inc. |
